03.01.2023 Drägerwerk AG & Co. KGaA  DE0005550602

EQS-News: Drägerwerk AG & Co. KGaA: Dräger redeems last participation certificates – streamlining of capital structure completed


 

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Corporate Action
Drägerwerk AG & Co. KGaA: Dräger redeems last participation certificates – streamlining of capital structure completed

03.01.2023 / 09:27 CET/CEST
The issuer is solely responsible for the content of this announcement.


Dräger redeems last participation certificates – streamlining of capital structure completed

Lübeck—Yesterday, Drägerwerk AG & Co. KGaA redeemed all 382,289 remaining series D profit participation certificates as planned in return for a payment of EUR 546.20 per participation certificate. This completes the redemption of all outstanding participation certificates. The series D participation certificates that have now been redeemed remain entitled to the dividend for the last time for the 2022 financial year. The dividend will be paid out after the annual general meeting, which will be held on May 6, 2023.

Stefan Dräger, Chairman of the Executive Board of Drägerwerk Verwaltungs AG: “With the redemption of the last participation certificates, an era that began with the issue of the first Dräger participation certificates 40 years ago has come to an end. The redemption streamlines our capital structure and thus strengthens our position on the capital market. In the future, the profit will exclusively benefit the shareholders.”

Since 1983, Dräger participation certificates have been issued in three series. In 2020, Dräger had terminated all outstanding participation certificates, divided into series A, K and D. The participation certificates of series A and K were already redeemed at the beginning of 2021 in accordance with the terms and conditions of the participation certificates. Now, Dräger has repaid and redeemed all remaining participation certificates of series D.

Disclaimer
This press release contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company’s knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company’s influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at www.draeger.com for information on alternative performance measures used.



03.01.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: [email protected]
Internet: www.draeger.com
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555071 Genussschein D
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart, Tradegate Exchange
EQS News ID: 1525525

 
End of News EQS News Service

1525525  03.01.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1525525&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023
Umsatzerlöse1 2.572,26 2.595,01 2.780,82 3.406,78 3.328,42 3.045,23 3.375,50
EBITDA1,2 240,00 147,91 193,71 521,07 421,00 55,80 315,00
EBITDA-Marge3 9,33 5,70 6,97 15,30 12,65 1,83
EBIT1,4 155,74 62,65 66,58 396,60 271,68 -88,61 166,43
EBIT-Marge5 6,05 2,41 2,39 11,64 8,16 -2,91 4,93
Jahresüberschuss1 98,50 34,90 33,79 249,89 154,27 -63,64 111,99
Netto-Marge6 3,83 1,34 1,22 7,34 4,64 -2,09 3,32
Cashflow1,7 143,34 4,09 164,42 459,98 384,89 -144,23 189,68
Ergebnis je Aktie8 4,12 1,42 1,38 10,19 7,13 -3,41 5,86
Dividende8 0,40 0,13 0,13 0,13 0,13 0,13 0,13
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: -

INVESTOR-INFORMATIONEN
©boersengefluester.de
Drägerwerk ST
WKN Kurs in € Einschätzung Börsenwert in Mio. €
555060 41,500 Kaufen 791,01
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
7,35 17,05 0,43 11,30
KBV KCV KUV EV/EBITDA
0,57 4,10 0,23 3,37
Dividende '22 in € Dividende '23 in € Div.-Rendite '23
in %
Hauptversammlung
0,13 1,74 4,19 09.05.2025
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
30.04.2025 25.07.2024 29.10.2024 03.04.2025
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-3,60% -5,81% -7,16% -12,26%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Drägerwerk AG & Co. KGaA  ISIN: DE0005550602 können Sie bei EQS abrufen


Medtech , 555060 , DRW8 , XETR:DRW8